These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cell. Chen Z; Plagemann PG J Virol Methods; 1997 May; 65(2):227-36. PubMed ID: 9186946 [TBL] [Abstract][Full Text] [Related]
9. Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired capability for high viremic persistent infection. Chen Z; Li K; Rowland RR; Anderson GW; Plagemann PG J Neurovirol; 1998 Oct; 4(5):560-8. PubMed ID: 9839654 [TBL] [Abstract][Full Text] [Related]
11. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein. Chen Z; Li K; Plagemann PG Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663 [TBL] [Abstract][Full Text] [Related]
12. Differential anti-Golgi complex autoantibody production following murine lactate dehydrogenase-elevating virus infection. Nozawa K; Fritzler MJ; Ikeda K; Takasaki Y; Satoh M; Chan EK Immunopharmacol Immunotoxicol; 2008; 30(1):13-25. PubMed ID: 18306101 [TBL] [Abstract][Full Text] [Related]
13. Detection of Lactate Dehydrogenase Elevating Virus in a Mouse Vivarium Using an Exhaust Air Dust Health Monitoring Program. Luchins KR; Mailhiot D; Theriault BR; Langan GP J Am Assoc Lab Anim Sci; 2020 May; 59(3):328-333. PubMed ID: 32079556 [TBL] [Abstract][Full Text] [Related]
14. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression. Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860 [TBL] [Abstract][Full Text] [Related]
15. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation. Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369 [TBL] [Abstract][Full Text] [Related]
16. Antibody-independent thrombocytopenia in lactate dehydrogenase-elevating virus-infected mice. Su D; Musaji A; Legrain S; Detalle L; van der Kaa J; Verbeek JS; Ryffel B; Coutelier JP J Virol; 2012 Nov; 86(22):12414-6. PubMed ID: 22933286 [TBL] [Abstract][Full Text] [Related]
17. Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution. Plagemann PG; Chen Z; Li K Arch Virol; 2001 Jul; 146(7):1283-96. PubMed ID: 11556706 [TBL] [Abstract][Full Text] [Related]
18. Multiplex fluorescent immunoassay for detection of mice infected with lactate dehydrogenase elevating virus. Adams V; Myles MH J Am Assoc Lab Anim Sci; 2013; 52(3):253-8. PubMed ID: 23849407 [TBL] [Abstract][Full Text] [Related]
19. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus. Broen JB; Bradley DS; Powell KM; Cafruny WA Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584 [TBL] [Abstract][Full Text] [Related]